Molecular biomarkers in stroke diagnosis and prognosis

Matthew B. Maas, Karen L. Furie

Research output: Contribution to journalReview articlepeer-review

90 Scopus citations


Serum biomarkers related to the cascade of inflammatory, hemostatic, glial and neuronal perturbations have been identified to diagnose and characterize intracerebral hemorrhage and cerebral ischemia. Interpretation of most markers is confounded by their latent rise, blood-brain barrier effects, the heterogeneity of etiologies and the wide range of normal values, limiting their application for early diagnosis, lesion size estimation and long-term outcome prediction. Certain hemostatic and inflammatory constituents have been found to predict response to thrombolysis and worsening due to infarct progression and secondary hemorrhage, offering a potential role for improved treatment selection and individualization of therapy. Biomarkers will become increasingly relevant for developing targets for neuroprotective therapies, monitoring response to treatment and as surrogate end points for treatment trials.

Original languageEnglish (US)
Pages (from-to)363-383
Number of pages21
JournalBiomarkers in Medicine
Issue number4
StatePublished - 2009


  • Biomarkers
  • Cytokines
  • Diagnosis
  • Inflammation
  • Prognosis
  • Severity
  • Stroke
  • Worsening

ASJC Scopus subject areas

  • Drug Discovery
  • Biochemistry, medical
  • Clinical Biochemistry


Dive into the research topics of 'Molecular biomarkers in stroke diagnosis and prognosis'. Together they form a unique fingerprint.

Cite this